Skip to Main content Skip to Navigation
Journal articles

Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study

Emmanuelle Leray 1, 2, * Sandra Vukusic 3, 4 Marc Debouverie 5, 6 Michel Clanet 7 Bruno Brochet 8 Jérôme de Sèze 9, 10, 11 Hélène Zéphir 12 Gilles Defer 13 Christine Lebrun-Frenay 14 Thibault Moreau 15 Pierre Clavelou 16 Jean Pelletier 17 Eric Berger 18 Philippe Cabre 19 Jean-Philippe Camdessanché 20 Shoshannah Kalson-Ray 21 Christian Confavreux 3 Gilles Edan 22, 23
Abstract : Background :Recent studies in multiple sclerosis (MS) showed longer survival times from clinical onset than older hospital-based series. However estimated median time ranges widely, from 24 to 45 years, which makes huge difference for patients as this neurological disease mainly starts around age 20 to 40. Precise and up-to-date reference data about mortality in MS are crucial for patients and neurologists, but unavailable yet in France. Objectives :Estimate survival in MS patients and compare mortality with that of the French general population. Methods :We conducted a multicenter observational study involving clinical longitudinal data from 30,413 eligible patients, linked to the national deaths register. Inclusion criteria were definite MS diagnosis and clinical onset prior to January, 1st 2009 in order to get a minimum of 1-year disease duration. Results :After removing between-center duplicates and applying inclusion criteria, the final population comprised 27,603 MS patients (F/M sex ratio 2.5, mean age at onset 33.0 years, 85.5% relapsing onset). During the follow-up period (mean 15.2 +/-10.3 years), 1569 deaths (5.7%) were identified; half related to MS. Death rates were significantly higher in men, patients with later clinical onset, and in progressive MS. Overall excess mortality compared with the general population was moderate (Standardized Mortality Ratio 1.48, 95% confidence interval [1.41-1.55]), but increased considerably after 20 years of disease (2.20 [2.10-2.31]). Conclusions :This study revealed a moderate decrease in life expectancy in MS patients, and showed that the risk of dying is strongly correlated to disease duration and disability, highlighting the need for early actions that can slow disability progression.
Document type :
Journal articles
Complete list of metadatas

Cited literature [34 references]  Display  Hide  Download

https://hal-amu.archives-ouvertes.fr/hal-01201656
Contributor : Administrateur Hal Amu <>
Submitted on : Thursday, September 17, 2015 - 4:35:06 PM
Last modification on : Tuesday, September 15, 2020 - 2:56:02 PM
Long-term archiving on: : Tuesday, December 29, 2015 - 8:32:47 AM

File

fetchObject.pdf
Publisher files allowed on an open archive

Identifiers

Citation

Emmanuelle Leray, Sandra Vukusic, Marc Debouverie, Michel Clanet, Bruno Brochet, et al.. Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study. PLoS ONE, Public Library of Science, 2015, 10 (7), pp.1-12. ⟨10.1371/journal.pone.0132033⟩. ⟨hal-01201656⟩

Share

Metrics

Record views

823

Files downloads

1159